Fig. 9From: An in vitro study of an Artocarpus heterophyllus substance as a hepatitis C antiviral and its combination with current anti-HCV drugsThe effect of a 1.5 μg/mL NaDCM dose combined common HCV treatments: A Ribavirin, B Cyclosporin A, C Simaprevir, and D TelaprevirBack to article page